Ingredion entered into a $1.475 billion senior unsecured delayed draw term loan (DDTL) facility on June 24, 2026. The facility consists of a $500 million Tranche A-1 and a $975 million Tranche B-1. Proceeds are designated to fund the cash consideration for the acquisition of Tate & Lyle PLC, refinance Tate & Lyle's existing debt, and cover related transaction fees. The agreement replaces the $1.475 billion Tranche A commitment of a previously announced $4.225 billion bridge facility, while the $2.75 billion Tranche B commitment remains. The facility includes financial covenants requiring a maximum leverage ratio of 3.5x (expandable to 4.0x for four quarters post-acquisition) and a minimum interest coverage ratio of 3.5x.